Agilent Technologies Inc. today announced the launch of a real-time reverse transcription PCR-based diagnostic kit for the detection of SARS-CoV-2 RNA.

Applied Biosystems and Agilent reach settlement agreement regarding real-time PCR thermal cyclers By Reuters September 18, 20071:12 PM PDTUpdated September 18, 2007 ...

Agilent Technologies Inc. today introduced a multimode real-time cell analyzer— the first of its kind— combining the best of non-invasive biosensor measurement with live cell imaging. “The ...